ZNF680 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.983900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.072160E-01
Normal-vs-Stage2
2.926300E-02
Normal-vs-Stage3
1.203640E-01
Normal-vs-Stage4
3.625000E-01
Stage1-vs-Stage2
8.397000E-01
Stage1-vs-Stage3
5.027600E-02
Stage1-vs-Stage4
7.036600E-01
Stage2-vs-Stage3
1.217250E-01
Stage2-vs-Stage4
5.319000E-01
Stage3-vs-Stage4
1.324220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.296100E-02
Normal-vs-AfricanAmerican
7.313900E-02
Normal-vs-Asian
3.723600E-02
Caucasian-vs-AfricanAmerican
7.543600E-01
Caucasian-vs-Asian
2.007200E-01
AfricanAmerican-vs-Asian
5.998200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.376430E-02
Normal-vs-Female
3.901600E-02
Male-vs-Female
6.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.410600E-01
Normal-vs-Age(41-60Yrs)
6.339900E-02
Normal-vs-Age(61-80Yrs)
1.629760E-02
Normal-vs-Age(81-100Yrs)
1.042370E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.844800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.282400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.587800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.037800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.485600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.178100E-02
Normal-vs-Daily Drinker
1.292460E-02
Normal-vs-Weekly Drinker
7.729900E-02
Normal-vs-Occasional Drinker
3.748400E-02
Normal-vs-Social Drinker
9.321700E-02
Non Drinker-vs-Daily Drinker
4.144600E-01
Non Drinker-vs-Weekly Drinker
4.795600E-01
Non Drinker-vs-Occasional Drinker
5.595800E-01
Non Drinker-vs-Social Drinker
5.200000E-01
Daily Drinker-vs-Weekly Drinker
9.235000E-01
Daily Drinker-vs-Occasional Drinker
1.546440E-01
Daily Drinker-vs-Social Drinker
1.714830E-01
Weekly Drinker-vs-Occasional Drinker
2.993400E-01
Weekly Drinker-vs-Social Drinker
2.841400E-01
Occasional Drinker-vs-Social Drinker
8.912200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.083600E-01
Normal-vs-Grade 2
9.838000E-01
Normal-vs-Grade 3
9.304200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.425410E-01
Grade 1-vs-Grade 3
1.415780E-02
Grade 1-vs-Grade 4
9.083600E-01
Grade 2-vs-Grade 3
7.015600E-02
Grade 2-vs-Grade 4
9.838000E-01
Grade 3-vs-Grade 4
9.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.097300E-03
Normal-vs-NonDiabetic
2.403800E-02
Diabetic-vs-NonDiabetic
7.666200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.660600E-03
Normal-vs-NoPancreatitis
1.398490E-02
Pancreatitis-vs-NoPancreatitis
1.549850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.275700E-03
Normal-vs-N1
3.737700E-02
N0-vs-N1
8.084400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.486170E-01
Normal-vs-TP53-NonMutant
6.654300E-02
TP53-Mutant-vs-TP53-NonMutant
2.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
